ORIGINAL RESEARCH article
Front. Psychiatry
Sec. Mood Disorders
Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1653998
This article is part of the Research TopicThe Genetic Intersection of Mental and Physical Health: Unraveling Shared Heritable Risk FactorsView all 3 articles
Investigating Biomarkers of Mitochondrial and Aging-Related Genes in Major Depressive Disorder Through Bioinformatics Analysis
Provisionally accepted- 1Xinjiang Medical University, Ürümqi, China
- 2People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Major depressive disorder (MDD) is a prevalent mental health condition in which mitochondrial dysfunction and cellular senescence contribute to its pathogenesis. This study aims to identify biomarkers related to mitochondria-associated genes (MRGs) and aging-related genes (ARGs) in MDD using bioinformatics. Methods: This study utilized data from GSE201332 and GSE52790, including 1,136 MRGs and 866 ARGs. Initially, candidate genes were selected by intersecting MRGs, ARGs, and differentially expressed genes (DEGs) derived from differential expression analysis in GSE201332. Biomarkers were identified through LASSO regression analysis of the candidate genes. The biomarkers were then evaluated using ROC curves, and artificial neural network (ANN) models were constructed. Subsequently, functional enrichment, immune-related analyses, drug predictions, and molecular docking were performed. Finally, the expression of biomarkers was validated using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Results: Seven candidate genes were identified from the intersection of 4,041 DEGs, 1,136 MRGs, and 866 ARGs, with SLC25A5, ALDH2, CPT1C, and IMMT identified as potential biomarkers for MDD through LASSO regression analysis. ROC curve analysis in both GSE201332 and GSE52790 showed that these biomarkers effectively distinguished between MDD and control samples, with AUC values exceeding 0.7. ANN models further confirmed the diagnostic potential of these biomarkers. Gene set enrichment analysis (GSEA) revealed significant enrichment of SLC25A5, CPT1C, and IMMT in pathways related to cellular protein complex assembly and chromatin organization. Immune infiltration analysis demonstrated significant positive correlations between SLC25A5, ALDH2, and IMMT and most of the 18 immune cell types. Molecular docking predictions identified ALDH2 and SLC25A5 as potential targets for specific drugs, with NITROGLYCERIN showing the best binding affinity to ALDH2 (-6.4 kcal/mol). RT-qPCR validation showed significantly lower expression of SLC25A5 and IMMT, and higher expression of CPT1C, in patients with MDD compared to controls (p < 0.05), consistent with bioinformatics This is a provisional file, not the final typeset article predictions. Conclusion: This study identified SLC25A5, ALDH2, CPT1C, and IMMT as biomarkers associated with MDD, offering insights into its molecular mechanisms.
Keywords: Major Depressive Disorder, Mitochondria-related genes, Aging-related genes, biomarker, molecular docking
Received: 25 Jun 2025; Accepted: 08 Sep 2025.
Copyright: © 2025 Chen, Tang, Gu and Shaohong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Zou Shaohong, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.